Neuropathological profile of mild cognitive impairment from a population perspective

Alzheimer Disease and Associated Disorders

Volumn 26, Issue 3, 2012, Pages 205-212

  Stephan, Blossom C M ^a   Matthews, Fiona E ^a   Hunter, Sally ^a   Savva, George M ^a   Bond, John ^b   McKeith, Ian G ^b   Ince, Paul ^c   Brayne, Carol ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

epidemiology; mild cognitive impairment (MCI); neuropathology

Indexed keywords

ALGORITHM; ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; DAILY LIFE ACTIVITY; DEMENTIA; DISEASE SEVERITY; DISEASES; FEMALE; GENOTYPE; HEART INFARCTION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HYPERTENSION; LONGITUDINAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE; SENSITIVITY ANALYSIS; STROKE; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; AGING; BRAIN; DEMENTIA; FEMALE; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT;

EID: 84865746486     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31822fc24d     Document Type: Review

References (62)

1. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment - beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240-246.
2. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
3. Bader Lange ML, Cenini G, Piroddi M, et al. Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease. Neurobiol Dis. 2008;29:456-464.
4. Butterfield DA, Poon HF St, Clair D, et al. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease. Neurobiol Dis. 2006;22:223-232.
5. Butterfield DA, Reed T, Perluigi M, et al. Elevated proteinbound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci Lett. 2006;397:170-173.
6. Butterfield DA, Reed TT, Perluigi M, et al. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: Implications for the role of nitration in the progression of Alzheimer's disease. Brain Res. 2007; 1148:243-248.
7. Cecarini V, Ding Q, Keller JN. Oxidative inactivation of the proteasome in Alzheimer's disease. Free Radic Res. 2007;41:673-680.
8. Cenini G, Sultana R, Memo M, et al. Elevated levels of proapoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease. J Cell Mol Med. 2007;9999(999A Please provide page range for reference "49").
9. Keller JN, Schmitt FA, Scheff SW, et al. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology. 2005;64:1152-1156.
10. Lovell MA, Markesbery WR. Oxidatively modified RNA in mild cognitive impairment. Neurobiol Dis. 2008;29:169-175.
11. Markesbery WR, Kryscio RJ, Lovell MA, et al. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol. 2005;58:730-735.
12. Reed T, Perluigi M, Sultana R, et al. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol Dis. 2008;30:107-120.
13. Sultana R, Butterfield DA. Regional expression of key cell cycle proteins in brain from subjects with amnestic mild cognitive impairment. Neurochem Res. 2007;32:655-662.
14. Wang J, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J Neurochem. 2006;96:825-832.
15. Williams TI, Lynn BC, Markesbery WR, et al. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol Aging. 2006;27:1094-1099.
16. Ding Q, Markesbery WR, Chen Q, et al. Ribosome dysfunction is an early event in Alzheimer's disease. J Neurosci. 2005;25:9171-9175.
17. Ding Q, Markesbery W, Cecarini V, et al. Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimers disease. Neurochem Res. 2006;31:705-710.
18. Jicha GA, Schmitt FA, Abner E, et al. Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiol Aging. 2010;31:1805-1813.
19. Lovell MA, Smith JL, Xiong S, et al. Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease. Neurotoxicity Res. 2005;7:265-271.
20. Smith JL, Xiong S, Markesbery WR, et al. Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain. Neuroscience. 2006;140:879-888.
21. Markesbery WR, Schmitt FA, Kryscio RJ, et al. Neuropathologic substrate of mild cognitive impairment. Arch Neurol. 2006;63:38-46.
22. Iacono D, O'Brien R, Resnick SM, et al. Neuronal hypertrophy in asymptomatic Alzheimer disease. J Neuropathol Exp Neurol. 2008;67:578-589.
23. Riudavets MA, Iacono D, Resnick SM, et al. Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons. Neurobiol Aging. 2007;28:1484-1492.
24. Guillozet AL, Weintraub S, Mash DC, et al. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol. 2003;60:729-736.
25. Petersen RC, Parisi JE, Dickson DW, et al. Neuropathologic Features of Amnestic Mild Cognitive Impairment. Arch Neurol. 2006;63:665-672.
26. Sabbagh MN, Shah F, Reid RT, et al. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging. Arch Neurol. 2006;63:1771-1776.
27. Scheff SW, Price DA, Schmitt FA, et al. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology. 2007;68:1501-1508.
28. Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006;66:1837-1844.
29. Bouras C, Kovari E, Herrmann FR, et al. Stereologic analysis of microvascular morphology in the elderly: Alzheimer disease pathology and cognitive status. J Neuropathol Exp Neurol. 2006;65:235-244.
30. Price JL, Morris JC. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol. 1999; 45:358-368.
31. Gomez-Isla T, Price JL, McKeel DW Jr, et al. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci. 1996;16:4491-4500.
32. Price JL, Ko AI, Wade MJ, et al. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol. 2001;58:1395-1402.
33. von Gunten A, Kovari E, Bussiere T, et al. Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease. Neurobiol Aging. 2006;27:270-277.
34. Bennett DA, Schneider JA, Bienias JL, et al. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005;64:834-841.
35. DeKosky ST, Ikonomovic MD, Styren SD, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol. 2002;51:145-155.
36. Mufson EJ, Chen EY, Cochran EJ, et al. Entorhinal cortex [beta]-amyloid load in individuals with mild cognitive impairment. Exp Neurol. 1999;158:469-490.
37. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet. 2001;357:169-175.
38. Brayne C, Richardson K, Matthews FE, et al. Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge city over-75s cohort (CC75C) study. J Alzheimers Dis. 2009;18:645-658.
39. Farias ST, Mungas D, Reed BR, et al. Progression of mild cognitive impairment to dementia in clinic- vs communitybased cohorts. Arch Neurol. 2009;66:1151-1157.
40. MRC CFAS. MRC CFAS Medical Research Council Cognitive Function and Ageing Study Group. Cognitive function and dementia in six areas of England and Wales: The distribution of MMSE. Psychol Med. 1998;28:319-335.
41. Copeland JR, DeweyME, Griffiths-Jones HM. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med. 1986;16:89-99.
42. Folstein M, Folstein S, McHugh PR. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
43. Roth M, Tym E, Mountjoy CQ, et al. A standarized instrument for the diagnoses of mental disorder in the elderly with special reference to the early detection of dementia. Brit J Psychiatry. 1986;149:698-709.
44. Townsend PB. Poverty in the United Kingdom: A Survey of Household Resources and Standards of Living. Harmondsworth: Pelican; 1979.
45. Matthews FE, Stephan BCM, Bond J, et al. Operationalisation of mild cognitive impairment: A graphical approach. PLoS Med. 2007;4:e304. doi:310.1371/journal.pmed.0040304.
46. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging. 1997;18: 351-357.
47. Matthews FE, Brayne C, Lowe J, et al. Epidemiological pathology of dementia: Attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med. 2009;6:e1000180.
48. Nicoll JA, Burnett C, Love S, et al. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol. 1997;41:716-721.
49. Schneider JA, Arvanitakis Z, Leurgans SE, et al. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009;66:200-208.
50. Matthews FE, Stephan BCM, McKeith I, et al. Two-year progression from mild cognitive impairment to dementia: To what extent do different definitions agree? J Am Geriatr Soc.56:; 2008:1424-1433.
51. Bussiere T, Gold G, Kovari E, et al. Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease. Neuroscience. 2003;117:577-592.
52. Pennanen C, Kivipelto M, Tuomainen S, et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging. 2004;25:303-310.
53. Selnes OA, Vinters HV. Vascular cognitive impairment. Nature. 2006;2:538-547.
54. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. J Am Med Assoc. 1997;277:813-817.
55. Launer LJ, Petrovitch H, Ross GW, et al. AD brain pathology: Vascular origins? Results from the HAAS autopsy study. Neurobiol Aging. 2008;29:1587-1590.
56. White L, Small BJ, Petrovitch H, et al. Recent clinicalpathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. J Geriatr Psychiatry Neurol. 2005;18:224-227.
57. Sonnen JA, Larson EB, Crane PK, et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol. 2007;62:406-413.
58. Nelson PT, Jicha GA, Schmitt FA, et al. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol. 2007;66: 1136-1146.
59. Stephan BC, Kurth T, Matthews FE, et al. Dementia risk prediction in the population: Are screening models accurate? Nat Rev Neurol. 2010;6:318-326.
60. Stephan BCM, Brayne C, McKeith I, et al. Mild cognitive impairment in the older population: Who is missed in classifications and does it matter? Int J Geriatr Psychiatry. 2008;23:863-871.
61. Stephan BCM, Savva GM, Brayne C, et al. Optimizing mild cognitive impairment for discriminating dementia risk in the general older population. Am J Geriatric Psych. 2010;18: 662-673.
62. Mosconi L, Brys M, Glodzik-Sobanska L, et al. Early detection of Alzheimer's disease using neuroimaging. Exp Gerontol. 2007;42:129-138.